These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6783679)

  • 1. Immunological nonidentity of Pseudomonas paucimobilis with Pseudomonas aeruginosa and Pseudomonas cepacia.
    Smalley DL; Ourth DD
    J Clin Microbiol; 1980 Sep; 12(3):439-41. PubMed ID: 6783679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-binding activity and antibody response with Pseudomonas paucimobilis and Flavobacterium multivorum.
    Smalley DL; Bradley ME
    Can J Microbiol; 1983 May; 29(5):619-21. PubMed ID: 6411314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera.
    Pitt TL; Erdman YJ
    J Med Microbiol; 1978 Feb; 11(1):15-23. PubMed ID: 413923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.
    Moody MR; Kessel RW; Young VM; Fiset P
    Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological study of antisera to to artificial O-antigen of Pseudomonas aeruginosa.
    Edvabnaya LS; Stanislavskii ES; Lany B; Schiller B; Bichowicz I
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):163-8. PubMed ID: 6166668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
    Guttman RM; Waisbren BA
    Clin Exp Immunol; 1975 Jan; 19(1):121-30. PubMed ID: 54231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens].
    Chekan LV; Stanislavskiĭ ES; Polkina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):92-6. PubMed ID: 6188300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal antibody response to Pseudomonas aeruginosa by adults with urinary tract infections.
    Smalley DL; Ourth DD
    J Clin Microbiol; 1979 Aug; 10(2):251-2. PubMed ID: 117024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
    Ahmadi H; Tabaraie B; Maleknia S; Pormirzagholi F; Nejati M; Hedayati MH
    J Infect Dev Ctries; 2012 Oct; 6(10):721-6. PubMed ID: 23103894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
    Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local IgA and IgG response to intratracheal immunization with Pseudomonas aeruginosa antigens.
    Johansen HK; Høiby N
    APMIS; 1992 Jan; 100(1):87-90. PubMed ID: 1536724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.
    Sokol PA; Kooi C; Hodges RS; Cachia P; Woods DE
    J Infect Dis; 2000 May; 181(5):1682-92. PubMed ID: 10823769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulins response in rabbit to single antigenic factors of leptospira. Investigations with two serovars from saprophytic leptospira.
    Cinco M; Dougan R; Panfili E
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):85-92. PubMed ID: 83752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.
    Sensakovic JW; Bartell PF
    Infect Immun; 1977 Nov; 18(2):304-9. PubMed ID: 411754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.